biostudies-literatureUnknown88(9)Hojlund MThe second-generation antipsychotic quetiapine is commonly used off-label for its anxiolytic and hypnotic properties. However, quetiapine is associated with problematic side-effects. We used Danish Medicinal Product Statistics and a 20% random sample of the Danish population's prescription fills (2001-2020) to describe the utilization of quetiapine and proportion of various prescriber types (general practitioner [GP], specialist in private practice, hospital physician and other prescribers) both in connection to first-time and subsequent prescriptions. In 2020, 92% of all quetiapine was dispensed outside hospitals and the average daily dispensed quantity of quetiapine per user corresponded to 100 mg/user/d. A GP issued 53% of first-time prescriptions and 75% of subsequent prescriptions forBritish journal of clinical pharmacology4224-4229https://www.ebi.ac.uk/biostudies/studies/S-EPMC9545446biostudies-literatureWho prescribes quetiapine in Denmark?PMC9545446Munk-Olsen THojlund MOlesen MRasmussen LPottegard AfalseWho prescribes quetiapine in Denmark?The second-generation antipsychotic quetiapine is commonly used off-label for its anxiolytic and hypnotic properties. However, quetiapine is associated with problematic side-effects. We used Danish Medicinal Product Statistics and a 20% random sample of the Danish population's prescription fills (2001-2020) to describe the utilization of quetiapine and proportion of various prescriber types (general practitioner [GP], specialist in private practice, hospital physician and other prescribers) both in connection to first-time and subsequent prescriptions. In 2020, 92% of all quetiapine was dispensed outside hospitals and the average daily dispensed quantity of quetiapine per user corresponded to 100 mg/user/d. A GP issued 53% of first-time prescriptions and 75% of subsequent prescriptions for2022-01-01T00:00:00Z2022 Sep2025-04-22T01:52:30.67Z2025-04-05T20:10:17.097ZS-EPMC95454463553544110.1111/bcp.15388